Journal of Medical Physics
 Home | Search | Ahead of print | Current Issue | Archives | Instructions | Subscription | Reader Login The official journal of AMPI, IOMP and AFOMP      
 Users online: 632  Home  EMail this page Print this page Decrease font size Default font size Increase font size 
Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   1999| April-June  | Volume 24 | Issue 2  
    Online since April 23, 2009

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
Cooperation Project : Medical Physics In Cancer Diagnosis And Therapy In Bangladesh
Ulrich Quast, Golam Abu Zakaria, Karl-Heinz Hoever, Gias Uddin Ahmad, Shaheen Akhter
April-June 1999, 24(2):69-73
Bangladesh requires 200 radiotherapy facilities, 4 are in use; 400 medical physicists are needed, 3 are employed. On a private basis, a DGMP working group started in 1996, annual workshops on 'Medical physics in cancer diagnosis and treatment', joined by many working physicists interested to become medical physicists. Basic topics were the principles, applications, acceptance, dosimetry and planning of 6 0 Co radiotherapy. In 1996, the Bangladesh Association of Physicists in Medicine (BMPA) was founded, a young scientific society requiring international co-operation. The long experience in Medical Physics in India, its neighbouring country, could be verfy helpful in providing excellent medical physics courses. To absorb new technology and science, it is necessary to change the education policy: creativity and innovativeness must be valued more than the old knowledge, being replaced quickly by new knowledge and new technologies.
[ABSTRACT]   Full text not available  [PDF]
  862 148 -
Quality Assurance Tests Of View-Boxes By A Home-Made Light Meter
Pratik Kumar, R C Yadav, M M Rehani
April-June 1999, 24(2):65-68
View-box is the last and important but often neglected link in the imaging Process. The quality assurance programme for view-boxes includes the measurement of the intensity of light-output (luminance) in Candella/m2 and the extent of variation in luminance (inhomogeneity) over the front surface of the view-box. An expensive instrument, photometer, is required to conduct both of these tests. Instead, an inexpensive Light Dependent Resistor (LDR) in combination with Ohm-meter may be used. The importance of quality assurance checks is indicated by the fact that majority of view-boxes (37.5%, 36 out of 49) had luminance less than 800 cd/m2, while the recommended level is about 1000 cd/m2 or more. Again, 55% view-boxes (27 out of 49) were found with inhomogeneity in luminance more than 10% while the permissible limit is up to 10%.
[ABSTRACT]   Full text not available  [PDF]
  822 177 -
Determining The Effective Electron Density Of Hip Prosthesis Using An Electronic Portal Imaging Device
Christine Alexander, Sherali Hussein, Kurt Luchka
April-June 1999, 24(2):39-43
A method of determining the effective electron density of hip prostheses using a scanning liquid ionization chamber (SLIC) electronic portal imaging device (EPID) is described. The method involves establishing an empirical relationship between the pixel intensity values (extracted from a portal image) and the corresponding equivalent thickness of an inhomogeneity such as a hip prosthesis. This is done using a composite phantom made of polystyrrene with embedded inhomogeneities of Aluminum, Copper and Lead. Results for 6 and 10 MV photons show that the relationship depends on the characteristics of the imaging device and on the photon energy, provided the atomic number (Z) of the inhomogeneity is sufficiently low such that the Compton effect remains the dominant photon interaction. The portal images of a pelvic phantom with prosthesis were then used to provide X-ray attenuation information, which allowed the determination of the equivalent path length containin9 the inhomogeneity and, therefore, its effective electron density.
[ABSTRACT]   Full text not available  [PDF]
  829 126 -
Variation In Electron Output And Percentage Depth Dose In Presence Of Lead Cutouts In Mevatron-74
Lalit M Aggarwal, Saji Oommen, V O Parthiban, Kamlesh Passi, R Vashistha, Singh Bhupinder
April-June 1999, 24(2):44-46
Electrons are widely used for the treatment of superficial malignant tumours. Radiation field is modified by placing the lead or Cerrobend cutouts on the application. For electrons, variation in output is not systematic with the increase or decrease in field size. In this paper, we have evaluated the variation in electron output, percentage depth dose and dmax for smaller fields with lead cutouts. It is observed that the relations give by various authors for predicting outputs for irregular fields did not agree with our data and variation of more than + 10% was found. So, we conclude that it is prudent to measure individualised output for irregularly shaped electron fields for calculating the tumour dose.
[ABSTRACT]   Full text not available  [PDF]
  725 201 -
Safety And Regulatory Aspects Of Intracoronary Irradiation
S D Sharma, U B Tripathi, B C Bhatt
April-June 1999, 24(2):56-62
Restenosis following balloon angioplasty occurs within six months in 30 - 50% of the cases. It is a major limiting factor in long term effectiveness of this procedure. Implantation of suitable intracoronary stent following balloon angioplasty reduces the rate of restenosis to about 20%. lntracoronary irradiation following balloon angioplasty is a recent development in the fields of interventional cardiology and radiation oncology for the management of benign diseases. Experience in the use of low doses of ionising radiation in other non-malignant diseases such as pterygia of the eye, keloids and heterotopic bone formation form the basis of this new application of radiation in human health care programme. A protocol has been developed at Radiological Physics and Advisory Division, Bhabha Atomic Research Centre, Mumbai, to scrutinise the proposals for the clinical trials involving intracoronary irradiation and to regulate the procedure from radiation safety standpoint. The regulatory requirements for clearance of clinical trials are: Catheterisation Laboratory with proper shielding: source container and storage facilities; availability of an RSO; ethical committee approval; facility for source calibration: and dosimetry; availability of protection level instruments; established procedure for the safe disposal of decayed source and waste; documentation of emergency procedures and patient informed consent form. This paper presents safety aspects associated with intracoronary brachytherapy techniques currently being tried out in some cardiology centres to inhibit restenosis.
[ABSTRACT]   Full text not available  [PDF]
  734 137 -
In-VIVO Dosimetric Study Of Carcinoma Of Uterine Cervix With FBX Solution In External Beam Therapy
Challapalli Srinivas, Shenoy K Kamalaksh, M Dinesh, Savitha, S K, Pai Kasturi, S S Supe, Y N Nagesha
April-June 1999, 24(2):47-50
To ensure accurate dose delivery to target site in external beam therapy and brachytherapy, various authors have conducted tests to assess the process of manual dose calculations. In-vivo dosimetric measurement is one of these methods to verify these calculations. In this study, an attempt has been made to compare the manually calculated dose to dose estimated using a chemical dosimeter (FBX) solution (In-vivo method, using polypropylene vials), on 12 patients of carcinoma of uterirne cervix in external beam therapy. Dose measured by FBX vial varies in the range oft 2 to 6.75%, as compared with manual calculations. These variations seen may be attributed to the location of the vial position in the vagina, with reference 111 the beam axis (may not be horizontal), off axis position, manual calculation variations and reproducibility of the FBX system etc. FBX dosimetry offers itself as an in-vivo method to estimate the dose delivered to the target site in external beam therapy.
[ABSTRACT]   Full text not available  [PDF]
  728 100 -
Diamond Detector Based Dosimetry Of Microselectron HDR 192lr Source
Surendra N Rustgi
April-June 1999, 24(2):51-55
A diamond detector was used to measure dose distributions around a Nucletron microSelectron 192lr HDR source. Relative 2D dose distributions along the source axis (0-7 cm) at distances ranging from 0.5 to 7 cm from the source center were measured in a water phantom. Relative dose rates transverse to the source axis were also measured at distances of 0.5-7 cm from the source center. The measured data was normalized to 1.115-cGy h-1U-1 along the source transverse axis at 1 cm. Excellent agreement between measured, two-dimensional dose distributions and corresponding published TLD/diode measurements and Monte Carlo calculations was observed.
[ABSTRACT]   Full text not available  [PDF]
  692 125 -
Restenosis And Radiation
M S S Murthy
April-June 1999, 24(2):63-64
Full text not available  [PDF]
  449 62 -
Health Drink
Geetha Sadagopan
April-June 1999, 24(2):74-74
Full text not available  [PDF]
  422 70 -
  Search this journal
  Advance Search
  Editorial Board 
  The Journal 
  The Association 
  Contact Us